Rate My Professor V. Dolzhenko

Anton V. Dolzhenko is an Associate Professor in the School of Pharmacy at Monash University Malaysia, where he serves as Discipline Head of Pharmaceutical Chemistry. He earned a degree with Distinction in Pharmacy in 2000 and a PhD in Medicinal Chemistry in 2004, both from the Perm State Pharmaceutical Academy in Russia. After completing his doctorate, he joined the Pharmacy Department at the National University of Singapore, contributing for six years. In 2010, he transitioned to the School of Pharmacy at Curtin University in Australia as a Senior Lecturer. Since 2013, he has been with Monash University Malaysia, rising to Associate Professor. Dolzhenko leads the NMR Campus Infrastructure Platform, delivering high-quality structural analysis services to internal and external users. He also holds an Adjunct Associate Professor position at Curtin University.

Dolzhenko's research explores synthetic and structural aspects of nitrogen heterocycles, emphasizing the development of innovative methods for synthesizing potentially bioactive compounds. His academic interests include medicinal and organic chemistry, green organic synthesis, heterocyclic chemistry, microwave-assisted organic synthesis, multicomponent reactions, structural and physical organic chemistry, and NMR spectroscopy. He has produced over 148 research outputs, with key publications such as '1,3,5-Triazinanes as C-N-C three-atom synthons in cycloaddition with β-aminocrotononitrile: Synthesis and structure of novel tetrahydropyrimidines' (2026, Journal of Molecular Structure), 'A new one-pot microwave-assisted synthesis and structural analysis of 6,N2,N4-trisubstituted 1,3,5-triazine-2,4-diamines' (2025, Journal of Molecular Structure), '1,3,5-Triazine as a promising scaffold in the development of therapeutic agents against breast cancer' (2024, European Journal of Medicinal Chemistry), 'Cyrene: A bio-based sustainable solvent for organic synthesis' (2022, Sustainable Chemistry and Pharmacy), '1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry' (2014, European Journal of Medicinal Chemistry), and 'Inhibitors of xanthine oxidase: scaffold diversity and structure-based drug design' (2019, ChemMedChem). His contributions have earned him the Most Inspiring Supervisor Award from the Monash University Postgraduate Association in 2018 and 2020, the Pro Vice-Chancellor’s Award for Excellence in Research (Postgraduate Research Supervision) in 2021, Senior Fellow of the Higher Education Academy in 2022, and Auditor of the ACS Malaysia Chapter in 2023.